According to 10x Genomics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.30036. At the end of 2023 the company had a P/S ratio of 10.7.
Year | P/S ratio | Change |
---|---|---|
2023 | 10.7 | 32.37% |
2022 | 8.08 | -76.19% |
2021 | 33.9 | -33.46% |
2020 | 51.0 | 70.84% |
2019 | 29.8 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Organovo ONVO | 41.6 | 685.67% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | 17.4 | 228.37% | ๐ฌ๐ง UK |
Novavax NVAX | 0.8375 | -84.20% | ๐บ๐ธ USA |
Novocure
NVCR | 2.61 | -50.81% | Jersey |